TickerFactsScreenerDevelopers

Theriva Biologics, Inc. (TOVX) — Operating Income

Annual figures by fiscal year, from SEC filings.

2012: -$17.30M2013: -$12.34M2014: -$20.50M2015: -$40.98M2016: -$39.25M2017: -$26.25M2018: -$17.57M2019: -$15.66M2020: -$10.16M2021: -$14.27M2022: -$21.58M2023: -$21.43M2024: -$26.35M2025: -$24.05M-$24.05M
2012Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$24.05M+8.7%
2024-$26.35M-22.9%
2023-$21.43M+0.7%
2022-$21.58M-51.2%
2021-$14.27M-40.5%
2020-$10.16M+35.1%
2019-$15.66M+10.9%
2018-$17.57M+33.1%
2017-$26.25M+33.1%
2016-$39.25M+4.2%
2015-$40.98M-99.9%
2014-$20.50M-66.2%
2013-$12.34M+28.7%
2012-$17.30M—